You are here: Home » Companies » News
Sterlite Technologies to acquire Italy-based optical products firm Optotec
Business Standard

DCGI rejects DRL's proposal, denies full marketing rights for Remdesivir

Emergency use authorisation to continue; recently, WHO had raised doubts about efficacy of drug in treatment of Covid-19 patients

Topics
Dr Reddy’s Laboratories  | Coronavirus | World Health Organization

Sohini Das  |  Mumbai 



remdesivir, coronavirus, drugs, covid, pharma
Dr Reddy's had presented the proposal along with clinical data for change in regulatory approval status for remdesivir injection from restricted emergency use to full marketing authorisation.

After the US drug regulator approved Gilead's antiviral drug remdesivir (Veklury) as treatment for Covid-19 amid reservations from the World Health Organization, the Indian regulator on Monday turned down a proposal by Dr Reddy's Laboratories for full marketing authorisation of remdesivir for Covid-19 patients.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Mon, November 02 2020. 20:18 IST

RECOMMENDED FOR YOU

.